肿瘤微环境对胃癌免疫治疗的影响

被引:9
作者
王晓露
蒋敬庭
吴昌平
机构
[1] 苏州大学附属第三医院肿瘤生物诊疗中心
关键词
胃癌; 肿瘤微环境; 免疫治疗;
D O I
暂无
中图分类号
R735.2 [胃肿瘤];
学科分类号
100112 [医学生物化学与分子生物学];
摘要
胃癌是消化系统死亡率较高的恶性肿瘤,手术切除、放疗、化疗等仍是目前主要的治疗手段,但效果并不理想。随着免疫学研究的发展,免疫治疗成为肿瘤综合治疗中研究的热点,许多新兴的手段如肿瘤疫苗、免疫卡控点治疗等展现出良好的应用前景。由于胃癌发病机制复杂,肿瘤异质性明显,还有很多问题亟待解决,肿瘤微环境是影响肿瘤的发生、发展、转移的重要因素,本文就肿瘤微环境对胃癌免疫治疗的影响方面的研究成果作一综述。
引用
收藏
页码:1038 / 1042
页数:5
相关论文
共 12 条
[1]
MAGE-3多肽纳米疫苗对小鼠胃癌种植瘤抑瘤效应研究.[J].杨君;李志花;周嘉嘉;陈汝福;程良正;周泉波;杨立群;.癌症.2010, 04
[2]
Translating gastric cancer genomics into targeted therapies.[J].Yvonne L.E. Ang;Wei Peng Yong;Patrick Tan.Critical Reviews in Oncology / Hematology.2016,
[3]
Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients [J].
Bol, Kalijn F. ;
Figdor, Carl G. ;
Aarntzen, Erik H. J. G. ;
Welzen, Marieke E. B. ;
van Rossum, Michelle M. ;
Blokx, Willeke A. M. ;
van de Rakt, Mandy W. M. M. ;
Scharenborg, Nicole M. ;
de Boer, Annemiek J. ;
Pots, Jeanette M. ;
Nordkamp, Michel A. M. Olde ;
van Oorschot, Tom G. M. ;
Mus, Roel D. M. ;
Croockewit, Sandra A. J. ;
Jacobs, Joannes F. M. ;
Schuler, Gerold ;
Neyns, Bart ;
Austyn, Jonathan M. ;
Punt, Cornelis J. A. ;
Schreibelt, Gerty ;
de Vries, I. Jolanda M. .
ONCOIMMUNOLOGY, 2015, 4 (08)
[4]
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J].
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Dikshit, Rajesh ;
Eser, Sultan ;
Mathers, Colin ;
Rebelo, Marise ;
Parkin, Donald Maxwell ;
Forman, David ;
Bray, Freddie .
INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (05) :E359-E386
[5]
Global Cancer Statistics, 2012 [J].
Torre, Lindsey A. ;
Bray, Freddie ;
Siegel, Rebecca L. ;
Ferlay, Jacques ;
Lortet-Tieulent, Joannie ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2015, 65 (02) :87-108
[6]
Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study [J].
Iveson, Timothy ;
Donehower, Ross C. ;
Davidenko, Irina ;
Tjulandin, Sergey ;
Deptala, Andrzej ;
Harrison, Mark ;
Nirni, Somanath ;
Lakshmaiah, Kuntegowdanahalli ;
Thomas, Anne ;
Jiang, Yizhou ;
Zhu, Min ;
Tang, Rui ;
Anderson, Abraham ;
Dubey, Sarita ;
Oliner, Kelly S. ;
Loh, Elwyn .
LANCET ONCOLOGY, 2014, 15 (09) :1007-1018
[7]
Interaction between gastric cancer stem cells and the tumor microenvironment [J].
Ishimoto, Takatsugu ;
Sawayama, Hiroshi ;
Sugihara, Hidetaka ;
Baba, Hideo .
JOURNAL OF GASTROENTEROLOGY, 2014, 49 (07) :1111-1120
[8]
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial [J].
Fuchs, Charles S. ;
Tomasek, Jiri ;
Yong, Cho Jae ;
Dumitru, Filip ;
Passalacqua, Rodolfo ;
Goswami, Chanchal ;
Safran, Howard ;
dos Santos, Lucas Vieira ;
Aprile, Giuseppe ;
Ferry, David R. ;
Melichar, Bohuslav ;
Tehfe, Mustapha ;
Topuzov, Eldar ;
Zalcberg, John Raymond ;
Chau, Ian ;
Campbell, William ;
Sivanandan, Choondal ;
Pikiel, Joanna ;
Koshiji, Minori ;
Hsu, Yanzhi ;
Liepa, Astra M. ;
Gao, Ling ;
Schwartz, Jonathan D. ;
Tabernero, Josep .
LANCET, 2014, 383 (9911) :31-39
[9]
Population Pharmacokinetics of Rilotumumab, a Fully Human Monoclonal Antibody Against Hepatocyte Growth Factor, in Cancer Patients [J].
Zhu, Min ;
Doshi, Sameer ;
Gisleskog, Per O. ;
Oliner, Kelly S. ;
Perez Ruixo, Juan Jose ;
Loh, Elwyn ;
Zhang, Yilong .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 103 (01) :328-336
[10]
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial [J].
Waddell, Tom ;
Chau, Ian ;
Cunningham, David ;
Gonzalez, David ;
Frances, Alicia ;
Okines, Clare ;
Wotherspoon, Andrew ;
Saffery, Claire ;
Middleton, Gary ;
Wadsley, Jonathan ;
Ferry, David ;
Mansoor, Wasat ;
Crosby, Tom ;
Coxon, Fareeda ;
Smith, David ;
Waters, Justin ;
Iveson, Timothy ;
Falk, Stephen ;
Slater, Sarah ;
Peckitt, Clare ;
Barbachano, Yolanda .
LANCET ONCOLOGY, 2013, 14 (06) :481-489